It’s Time for FDA to Overcome Barriers to Sharing Confidential Information, Two Experts Say

The FDA has long erred on the side of extreme caution when it comes to sharing confidential commercial information and trade secrets out of fear it might violate federal law by disclosing them.
Source: Drug Industry Daily